Clinical trials
Phase 2 Neutropenia trials in China
Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.
9 trials match Source: ClinicalTrials.gov registrations
Trials started per year
By phase, 2000 to 2026.
| Category | Trials |
|---|---|
| 2011 | 1 |
| 2013 | 2 |
| 2014 | 1 |
| 2017 | 1 |
| 2018 | 1 |
| 2025 | 1 |
| 2026 | 2 |
Status
Trials by registry status. Select a bar to filter.
| Category | Trials |
|---|---|
| Completed | 5 |
| Recruiting | 3 |
| Unknown status | 1 |
Top lead sponsors
A sponsor with a page on Pharma Observatory links to it.
| Category | Trials |
|---|---|
| Affiliated Hospital of Nantong University | 1 |
| Chongqing University Cancer Hospital | 1 |
| EVIVE Biotechnology | 1 |
| Hangzhou Jiuyuan Gene Engineering Co. Ltd., | 1 |
| Jiangsu HengRui Medicine Co., Ltd. | 1 |
| Qilu Pharmaceutical Co., Ltd. | 1 |
| Second Affiliated Hospital, Zhejiang University, School of Medicine | 1 |
| Tianjin SinoBiotech Ltd. | 1 |
| Xiamen Amoytop Biotech Co., Ltd. | 1 |
Top conditions
MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.
| Category | Trials |
|---|---|
| Neutropenia | 9 |
| Breast Neoplasms | 4 |
| Febrile Neutropenia | 4 |
| Carcinoma, Non-Small-Cell Lung | 1 |
| Leukopenia | 1 |
| Thoracic Neoplasms | 1 |
| Uterine Cervical Neoplasms | 1 |
Trials
Showing 1 to 9 of 9. Each trial links to its page on Pharma Observatory.
Recently changed trials
Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.
No changes to these trials in the last 7 days.
Go deeper on Pharma Observatory
Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.